Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytes.
Matteo SimonelliPasquale PersicoArianna CapucettiClaudia CarenzaSara FranzeseElena LorenziAngelo DipasqualeAgnese LosurdoLaura GiordanoFederico PessinaPierina NavarriaLetterio S PolitiDomenico MavilioMassimo LocatiSilvia Della BellaArmando SantoroRaffaella BonecchiPublished in: Neuro-oncology advances (2021)
promoter methylation identifies patients who benefit more from immunotherapy. Monitoring dynamic changes of innate immune cell populations may help to predict clinical outcomes.